Regulatory role of the cannabinoid CB2receptor in stress-induced neuroinflammation in mice

The Concise Guide to PHARMACOLOGY 2013/14: Transporters

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Endocannabinoid System and the Brain

(2012) Raphael Mechoulam et al.   Annual Review of Psychology

Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?

(2012) Rai Khalid Farooq et al.   BEHAVIOURAL BRAIN RESEARCH

Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders

(2012) Tiziana Bisogno et al.   CNS & Neurological Disorders-Drug Targets

Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice

(2012) S. Y. Romero-Zerbo et al.   JOURNAL OF NEUROENDOCRINOLOGY

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

(2012) Ana María Martín-Moreno et al.   Journal of Neuroinflammation

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

(2012) Auxiliadora Aracil-Fernández et al.   NEUROPSYCHOPHARMACOLOGY

Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury

(2011) Sabina Adhikary et al.   JOURNAL OF NEUROTRAUMA

CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity

(2011) Emmanuel S Onaivi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

(2011) Antonio Ortega-Alvaro et al.   NEUROPSYCHOPHARMACOLOGY

Immune system to brain signaling: Neuropsychopharmacological implications

(2011) Lucile Capuron et al.   PHARMACOLOGY & THERAPEUTICS

Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection

(2011) Juan G. Zarruk et al.   STROKE

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

CB2: a cannabinoid receptor with an identity crisis

(2010) Brady K Atwood et al.   BRITISH JOURNAL OF PHARMACOLOGY

Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors

(2010) MS García-Gutiérrez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Interaction between cytokines, cannabinoids and the nervous system

(2010) Lucie Jean-Gilles et al.   IMMUNOBIOLOGY

The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases

(2010) Grégory Conductier et al.   JOURNAL OF NEUROIMMUNOLOGY

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

(2010) María S García-Gutiérrez et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine

(2010) Alexander Ternianov et al.   NEUROBIOLOGY OF AGING

Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation

(2010) Silvia Zoppi et al.   NEUROPSYCHOPHARMACOLOGY

Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?

(2010) Karen Wager-Smith et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

(2009) Javier Palazuelos et al.   BRAIN

The endocannabinoid system as a target for the treatment of motor dysfunction

(2009) Javier Fernández-Ruiz   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

(2009) Francis Rodriguez Bambico et al.   CURRENT PHARMACEUTICAL DESIGN

Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation

(2009) Guy A. Cabral et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF-κB

(2009) Fernando Correa et al.   GLIA

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

(2009) F. Loría et al.   NEUROBIOLOGY OF DISEASE

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors

(2009) A. Castillo et al.   NEUROBIOLOGY OF DISEASE

The Stressed CNS: When Glucocorticoids Aggravate Inflammation

(2009) Shawn F. Sorrells et al.   NEURON

CNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control

(2008) Susanne Wolf et al.   CURRENT PHARMACEUTICAL DESIGN

The CB2Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

(2008) Javier Palazuelos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

(2008) I. Racz et al.   JOURNAL OF NEUROSCIENCE

Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms

(2008) Borja García-Bueno et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

CB2receptor-mediated migration of immune cells: it can go either way

(2007) A M Miller et al.   BRITISH JOURNAL OF PHARMACOLOGY